Search

everythinglearnresearchcommunity

for

Search:↓

Men taking 5-alpha reductase inhibitors for prostate issues may be less likely to experience severe COVID-19, but it doesn't prevent ICU admission or death.

Most care for benign prostatic hyperplasia follows guidelines, but 5-α reductase inhibitors are often used incorrectly.

Saw palmetto may improve urinary symptoms with fewer sexual side effects compared to some medications.

The letter is skeptical about the effectiveness of anti-androgen therapy for COVID-19 and calls for strong evidence from clinical trials.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

The document suggests that more research is needed to confirm if baldness can indicate a higher risk of severe COVID-19 in men.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

Certain medications, especially 5-α reductase inhibitors and neuropsychiatric drugs, are often linked to erectile dysfunction.

Hormonal contraceptives and therapies regulate organ functions and treat various conditions.

The body's change of testosterone into DHT is not necessary for testosterone's muscle and sexual effects.

Current treatments for postmenopausal frontal fibrosing alopecia stop hair loss but don't regrow hair.

Dutasteride is cheaper than finasteride for treating benign prostatic hyperplasia.

New oral treatment, finasteride, effectively and safely treats common hair loss.

Polygenic risk scores can predict the risk and outcomes of benign prostatic hyperplasia.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

Saw palmetto may cause erectile dysfunction and needs better safety monitoring.

The letter suggests testosterone replacement therapy might worsen COVID-19 outcomes.

Hair loss is linked to heart disease and metabolic syndrome, and while current treatments vary in effectiveness, more research is needed for better solutions.

Men with thinner hair from genetic hair loss may be more likely to have an enlarged prostate.

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.

Long-term medication for enlarged prostate might not clearly affect the timing or outcomes of later surgery.

More research needed to confirm finasteride as standard treatment for FFA.

The document discusses new insights into how hormones affect male sexual health and related conditions.

Finasteride may help prevent prostate cancer.

Perifollicular fibrosis hinders hair regrowth in androgenetic alopecia, and new treatments targeting fibrosis are needed.

Personalized hair loss treatments are needed for transgender individuals, but more research is required.

Most dermatologists think post-finasteride syndrome is rare, possibly psychiatric, and needs more research.

Finasteride, dutasteride, and oral minoxidil are effective for treating hair loss, with spironolactone as an option for women.

Finasteride improves prostate cancer prediction by adjusting kallikrein marker levels.

Finasteride effectively treats male hair loss, with oral and topical forms improving hair growth, but oral use may have side effects.